240
Participants
Start Date
March 17, 2022
Primary Completion Date
June 21, 2024
Study Completion Date
June 21, 2024
MiniMed 780G System
780G System used with Insulin Fiasp® (Insulin Aspart Injection)
John Hunter Childrens Hospital, New Lambton
Barry J Reiner MD, LLC, Baltimore
Physicians East, Greenville
Endocrine Research Solutions, Roswell
Atlanta Diabetes Associates, Atlanta
University of South Florida, Tampa
Medical Investigations, Inc., Little Rock
Diabetes and Glandular Disease Clinic, P.A., San Antonio
Barbara Davis Center for Diabetes, Aurora
Rocky Mountain Clinical Research, Idaho Falls
The Docs, LLC, Las Vegas
Rady's Children's Hospital, San Diego
Valley Research, Fresno
Sutter Institute for Medical Research, Sacramento
Rainier Clinical Research Center, Renton
MultiCare Institute for Research & Innovation, Tacoma
Alberta Children's Hospital Research Institute, Calgary
LMC Clinical Research, Toronto
Medtronic Diabetes
INDUSTRY